Debomita Bhattacharya

My research is centered on structure-based drug design, specifically targeting the synthesis of inhibitors for epigenetic modulators. In the Schweizer Group, my work focuses on the development of novel unnatural aminoglycosides, aiming to discover potent antibacterial agents effective against Gram-negative bacteria.

• Schweizer Lab